TELA Bio, Inc. Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TELA Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TELA Bio, Inc. for November 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 28.65 | 10,775 | 308,704 | 10,775 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 1.16 | 10,775 | 12,499 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 351,271 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 179,685 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 14,225 | 0 | 154,085 | 139.9 K to 154.1 K (+10.17 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 7,277 | 0 | 139,860 | 132.6 K to 139.9 K (+5.49 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 28.65 | 10,775 | 308,704 | 10,775 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Option Exercise | C | 0.00 | 14,329,052 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 1.16 | 10,775 | 12,499 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Buy | C | 0.00 | 580,357 | 0 | 774,056 | 193.7 K to 774.1 K (+299.62 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 351,271 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 179,685 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 14,225 | 0 | 154,085 | 139.9 K to 154.1 K (+10.17 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 7,277 | 0 | 139,860 | 132.6 K to 139.9 K (+5.49 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Option Exercise | C | 0.00 | 14,329,052 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Buy | C | 0.00 | 580,357 | 0 | 774,056 | 193.7 K to 774.1 K (+299.62 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 28.65 | 446,813 | 12,801,192 | 446,813 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 1.16 | 446,813 | 518,303 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 12,763,434 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 8,530,145 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 516,947 | 0 | 1,751,100 | 1.2 M to 1.8 M (+41.89 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 345,489 | 0 | 1,234,153 | 888.7 K to 1.2 M (+38.88 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | P | 13.00 | 153,846 | 1,999,998 | 888,664 | 734.8 K to 888.7 K (+20.94 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 28.65 | 446,813 | 12,801,192 | 446,813 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 1.16 | 446,813 | 518,303 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 12,763,434 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 8,530,145 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 516,947 | 0 | 1,751,100 | 1.2 M to 1.8 M (+41.89 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 345,489 | 0 | 1,234,153 | 888.7 K to 1.2 M (+38.88 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | P | 13.00 | 153,846 | 1,999,998 | 888,664 | 734.8 K to 888.7 K (+20.94 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 1,665 | 47,702 | 1,665 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 1,665 | 1,931 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 123,653 | 3,542,658 | 123,653 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 123,653 | 143,437 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 72,417 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 5,377,928 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 6,643 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 493,357 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 217,816 | 0 | 498,606 | 280.8 K to 498.6 K (+77.57 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 1,665 | 47,702 | 1,665 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 19,982 | 0 | 280,790 | 260.8 K to 280.8 K (+7.66 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 1,665 | 1,931 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 2,931 | 0 | 15,875 | 12.9 K to 15.9 K (+22.64 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 123,653 | 3,542,658 | 123,653 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 269 | 0 | 12,944 | 12.7 K to 12.9 K (+2.12 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 123,653 | 143,437 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 75,901 | 986,713 | 260,808 | 184.9 K to 260.8 K (+41.05 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 72,417 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 10,220 | 132,860 | 12,675 | 2.5 K to 12.7 K (+416.29 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 5,377,928 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 6,643 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 493,357 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 217,816 | 0 | 498,606 | 280.8 K to 498.6 K (+77.57 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 19,982 | 0 | 280,790 | 260.8 K to 280.8 K (+7.66 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Brennan Nora | Chief Financial Off ... | Option Exercise | C | 0.00 | 86,200 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 2,931 | 0 | 15,875 | 12.9 K to 15.9 K (+22.64 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Brennan Nora | Chief Financial Off ... | Buy | C | 0.00 | 3,491 | 0 | 3,668 | 177 to 3.7 K (+1,972.32 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 269 | 0 | 12,944 | 12.7 K to 12.9 K (+2.12 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 28.65 | 1,665 | 47,702 | 1,665 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 75,901 | 986,713 | 260,808 | 184.9 K to 260.8 K (+41.05 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 1.16 | 1,665 | 1,931 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 10,220 | 132,860 | 12,675 | 2.5 K to 12.7 K (+416.29 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 28.65 | 123,653 | 3,542,658 | 123,653 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 1.16 | 123,653 | 143,437 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 72,417 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 5,377,928 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Brennan Nora | Chief Financial Off ... | Option Exercise | C | 0.00 | 86,200 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 6,643 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Brennan Nora | Chief Financial Off ... | Buy | C | 0.00 | 3,491 | 0 | 3,668 | 177 to 3.7 K (+1,972.32 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 493,357 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 28.65 | 1,665 | 47,702 | 1,665 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 217,816 | 0 | 498,606 | 280.8 K to 498.6 K (+77.57 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 1.16 | 1,665 | 1,931 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 19,982 | 0 | 280,790 | 260.8 K to 280.8 K (+7.66 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 28.65 | 123,653 | 3,542,658 | 123,653 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 2,931 | 0 | 15,875 | 12.9 K to 15.9 K (+22.64 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 1.16 | 123,653 | 143,437 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 269 | 0 | 12,944 | 12.7 K to 12.9 K (+2.12 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 72,417 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | P | 13.00 | 75,901 | 986,713 | 260,808 | 184.9 K to 260.8 K (+41.05 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 5,377,928 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | P | 13.00 | 10,220 | 132,860 | 12,675 | 2.5 K to 12.7 K (+416.29 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 6,643 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 493,357 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 28.65 | 12,931 | 370,473 | 12,931 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 217,816 | 0 | 498,606 | 280.8 K to 498.6 K (+77.57 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 1.16 | 12,931 | 15,000 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 19,982 | 0 | 280,790 | 260.8 K to 280.8 K (+7.66 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 0.00 | 315,086 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 2,931 | 0 | 15,875 | 12.9 K to 15.9 K (+22.64 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 0.00 | 197,511 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | C | 0.00 | 269 | 0 | 12,944 | 12.7 K to 12.9 K (+2.12 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Buy | C | 0.00 | 12,760 | 0 | 78,887 | 66.1 K to 78.9 K (+19.30 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | P | 13.00 | 75,901 | 986,713 | 260,808 | 184.9 K to 260.8 K (+41.05 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Buy | C | 0.00 | 7,999 | 0 | 66,127 | 58.1 K to 66.1 K (+13.76 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Buy | P | 13.00 | 10,220 | 132,860 | 12,675 | 2.5 K to 12.7 K (+416.29 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 28.65 | 1,976 | 56,612 | 1,976 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 1.16 | 1,976 | 2,292 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 28.65 | 12,931 | 370,473 | 12,931 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 0.00 | 120,699 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 1.16 | 12,931 | 15,000 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 0.00 | 315,086 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Buy | C | 0.00 | 4,887 | 0 | 10,510 | 5.6 K to 10.5 K (+86.91 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Option Exercise | C | 0.00 | 197,511 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Buy | C | 0.00 | 2,025 | 0 | 5,623 | 3.6 K to 5.6 K (+56.28 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Buy | C | 0.00 | 12,760 | 0 | 78,887 | 66.1 K to 78.9 K (+19.30 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Option Exercise | C | 28.65 | 148,499 | 4,254,496 | 148,499 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | PERSENAIRE MAARTEN | Chief Medical Offic ... | Buy | C | 0.00 | 7,999 | 0 | 66,127 | 58.1 K to 66.1 K (+13.76 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 28.65 | 1,976 | 56,612 | 1,976 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Option Exercise | C | 1.16 | 148,499 | 172,259 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 1.16 | 1,976 | 2,292 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Option Exercise | C | 28.65 | 31,168 | 892,963 | 31,168 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 0.00 | 120,699 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Option Exercise | C | 1.16 | 31,168 | 36,155 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Option Exercise | C | 0.00 | 7,051,009 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Buy | C | 0.00 | 4,887 | 0 | 10,510 | 5.6 K to 10.5 K (+86.91 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Option Exercise | C | 0.00 | 1,479,951 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Science Offic ... | Buy | C | 0.00 | 2,025 | 0 | 5,623 | 3.6 K to 5.6 K (+56.28 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Buy | C | 0.00 | 285,580 | 0 | 505,281 | 219.7 K to 505.3 K (+129.99 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Friedman Ashley | Director | Buy | C | 0.00 | 59,940 | 0 | 106,052 | 46.1 K to 106.1 K (+129.99 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Option Exercise | C | 28.65 | 446,813 | 12,801,192 | 446,813 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Option Exercise | C | 1.16 | 446,813 | 518,303 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Option Exercise | C | 0.00 | 12,763,434 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Option Exercise | C | 0.00 | 8,530,145 | 0 | 0 | |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Buy | C | 0.00 | 516,947 | 0 | 1,751,100 | 1.2 M to 1.8 M (+41.89 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Buy | C | 0.00 | 345,489 | 0 | 1,234,153 | 888.7 K to 1.2 M (+38.88 %) |
| Nov 13 2019 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Buy | P | 13.00 | 153,846 | 1,999,998 | 888,664 | 734.8 K to 888.7 K (+20.94 %) |